BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36814799)

  • 1. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
    Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
    J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.
    Ribeiro VB; Kogure GS; Lopes IP; Silva RC; Pedroso DCC; Ferriani RA; Furtado CLM; Reis RMD
    Arch Endocrinol Metab; 2019 Jul; 63(4):417-426. PubMed ID: 31365630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
    Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
    Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.
    Banu H; Morshed MS; Sultana T; Shah S; Afrine S; Hasanat MA
    J Hum Reprod Sci; 2022; 15(1):27-33. PubMed ID: 35494190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index.
    Kogure GS; Ribeiro VB; Mendes MC; Ferriani RA; Furtado CLM; Dos Reis RM
    Arch Endocrinol Metab; 2023 May; 67(5):e000627. PubMed ID: 37249458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome.
    Han W; Zhang M; Wang H; Yang Y; Wang L
    Front Endocrinol (Lausanne); 2023; 14():1279978. PubMed ID: 38269246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
    Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
    Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel obesity- and lipid-related indices as predictors of abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
    Yin Q; Yan X; Cao Y; Zheng J
    BMC Endocr Disord; 2022 Nov; 22(1):272. PubMed ID: 36348340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.
    Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.
    Feng Y; Li M; Li X; Tang Q; Li X; Ji X; Tian W; Zhang H
    Reprod Sci; 2024 Apr; ():. PubMed ID: 38649666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.
    Techatraisak K; Wongmeerit K; Dangrat C; Wongwananuruk T; Indhavivadhana S
    Gynecol Endocrinol; 2016; 32(4):276-80. PubMed ID: 26503544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome.
    Fruzzetti F; Fidecicchi T; Benelli E; Baldari F; Tonacchera M
    J Endocrinol Invest; 2024 Apr; 47(4):927-936. PubMed ID: 37907709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
    Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
    Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.